<html>

        <head>
        <link href="../style1.css" rel="stylesheet" type="text/css">
        </head>
        <table border = 1>
        <tr>
        <th>PubMedID</th>
        <th>Sentence</th>
        <th>First Gene</th>
        <th>Second Gene</th>
        <th>Interaction</th>
        </tr>
        <body>
<tr class = "cellcolor">
<td>24293393</td>
<td>Numerous epidemiological and clinical studies have pinpointed anaplastic lymphoma kinase (ALK) and MYCN as potent governors for NB malignant behavior</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24293393</td>
<td>ALK and MYCN amplification and constitutive active mutations are common in high-risk NB patients</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24293393</td>
<td>However, there is still lack of evidence showing that a small molecule  compound could simultaneously inhibits ALK and MYCN and plays strong negative regulatory roles in NB</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24293393</td>
<td>Interestingly, our data suggests that NB cells with both ALK and MYCN amplification/mutation are more sensitive to 17-DMAG treatment, while NB cells with only ALK or MYCN amplification are less sensitive  and NB cells without ALK or MYCN amplification/mutation are least sensitive</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24293393</td>
<td>Moreover, we also found that knocking down ALK and MYCN additively inhibits NB cell growth and that transduction of MYCN largely abolished the ALK-dependent NB  cell growth, indicating that there is a cross-talk between MYCN and ALK signaling machinery</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24293393</td>
<td>Our results provide proof-of-principle that 17-DMAG strongly inhibits  NB cell growth by targeting both ALK and MYCN</td>
<td>ALK</td>
<td>MYCN</td>
<td>None</td>
</tr>
